Direct-to-consumer advertising

19, 2013 Direct-to-Consumer Drug Advertising: Ethical or Not? The United States and New Zealand are the only developed countries that allow direct-to-consumer advertising. Whether the practice of direct to consumer advertising is beneficial to the consumers or not is a highly debated subject with both positions presenting sound reasoning for their position. Whether the practice is beneficial or not to the consumer is not the question, but rather, is advertising prescription drugs

To begin the those who support direct to consumer advertising claim that this method educates consumers and allows them to take charge of their health. Their strongest argument for direct to consumer advertising is that “informing consumers will benefit the drive for health care reform” (Delbaere). Delbaere also suggests that consumers can benefit from theses ads by having access to different information sources about drugs and other treatment options rather than relying solely on health care providers

From the Pharmaceutical industry perspective direct-to-consumer advertising builds a sense of trust between consumer and drug manufactures; as well as providing consumers with knowledge of illnesses and treatment options. The Pharmaceutical Companies feel that exposing viewers/readers to a high level of symptoms it will prompt the consumers will create and open dialog with their physicians about their health issues, due to the advertisement consumers are aware of side effects allowing them under

have resulted from the desire to increase revenue and profits for the firm. Although the main focus of a business is to maximize profits, these marketing methods have resulted in harm to the society and have resulted in unethical behavior. The direct-to-consumer advertisements can be justified to an extent. Through this the industry educates the public about various drugs and their benefits, it could help educate the general population, and in a world

This paper takes the stand that direct-to-consumer (DTC) advertising of pharmaceutical drugs is unethical. This stand is based on the belief that many developed countries in the world have banned such kind of advertising because they believe that it is unethical. I believe that the advertising of pharmaceutical drugs is unethical because it gives consumers hope that a specific drug can cure their disease. However, this might not be the case as only a qualified medical practitioner can prescribe the

to consumers. Every one of us have seen the commercials depicting a loving middle- aged couple holding hands by a lake or in a luxurious hot tub together. This brand of advertising known as Direct-to-consumer advertising or DTCA. DTCA is flooding our televisions , internet , and magazines. The spending of the pharmaceutical companies on marketing has surged significantly. Unquestionably, television ads are the most prominent form of health communication To engage in further discussion, there

the screen. Promotion of pharmaceuticals to consumers is referred to as direct-to-consumer (DTC) advertising. In the United States, pharmaceutical suppliers are now the leading communicator of health information to the mass public. Whereas the FDA does oversee the distribution of such media, the question of consumer competency raises concern. Those who support these advertisements suggest the information is beneficial to the consumer. Such advertising does provide crucial

Pharmaceutical companies spend billions of dollars advertising pharmaceutical drugs to consumers, medical journals, and healthcare providers. In fact, according to Mahon’s publication “Impact of Direct-To-Consumer Advertising on Healthcare Providers and Consumers,” for every one dollar that pharmaceutical companies spent on advertising, the sales quadrupled to a shocking $4.20 (417). What is even more frightening, is that this extremely profitable return on advertisements is continuing to grow

Many argue DTC advertising does not prevent future health problems by warning patients early on with symptoms; rather it raises awareness to health problems they may not have. Additionally, highlighting possible solutions in which patients are more likely to consult their physicians in an interest of taking such medication (“Pharmaceutical Industry”). Direct to consumer advertising has escalated throughout the past few years and drug marketers in

In conclusion, Direct to Consumer Advertising or DTCA, is a controversial method of advertising used to inform consumers about drug information. Due to this controversy, there are many opinions concerning how much DTCA should be regulated. For the past few decades, opinions about regulations has changed greatly. After considering the benefits and concerns regarding DTCA, we decided to take a legislative approach to DTCA. We came to this conclusion because DTCA is regulated by the FDA. Our goal was